We have been notified about the shortage of Pegasys (peginterferon alfa 2a) injection 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
This medicine is used to treat chronic hepatitis B (CHB) and chronic hepatitis C (CHC), and is commonly prescribed off-label to treat myeloproliferative neoplasms (MPNs).
It is currently being exclusively supplied to patients through the Pegasys Home Delivery Program.
We have approved the supply of an overseas-registered product to help during the shortage. Patients should contact their doctor to review their individual situation.
Please go to About the shortage of Pegasys (peginterferon alfa-2a) injection for more information.
You can also go to the Medicine Shortage Reports Database- external site (search for ‘Pegasys’) for the most up-to-date information.